An in-depth characterization of CD4+ T-cell senescence in patients with MS by combining the maturation stage and the downregulation of CD28 and CD27 costimulatory molecules might therefore facilitate a more detailed characterization of pathogenic CD4+ T cells. The gene discussed is CD27; the disease is myeloid sarcoma.